Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers (DE:SHL)
OTHER OTC:SHL
SHL Stock Chart & Stats
€48.72
-€0.18(-0.35%)
At close: 4:00 PM EST
€48.72
-€0.18(-0.35%)
Day’s Range― - ―
52-Week Range€40.97 - €58.48
Previous CloseN/A
Volume31.64K
Average Volume (3M)1.32M
Market Cap
€49.92B
Enterprise Value€64.36B
Total Cash (Recent Filing)€2.17B
Total Debt (Recent Filing)€15.06B
Price to Earnings (P/E)23.2
Beta1.07
Next Earnings
Feb 05, 2026EPS Estimate
0.46Next Dividend Ex-DateN/A
Dividend Yield2.13%
Share Statistics
EPS (TTM)0.68
Shares Outstanding1,128,000,000
10 Day Avg. Volume1,423,722
30 Day Avg. Volume1,318,446
Financial Highlights & Ratios
PEG Ratio2.46
Price to Book (P/B)2.86
Price to Sales (P/S)2.20
P/FCF Ratio22.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€54.44Price Target Upside11.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash FlowFree cash flow was EUR197mn, up 64% y/y, significantly higher than the previous year, supporting continued investment in innovation and shareholder returns.
InnovationSiemens Healthineers is at the forefront of innovation and was the first company to obtain FDA approval for the first photon-counting CT for clinical use and continues to be the only company with such technology commercially available.
Revenue GrowthRevenue grew 6.8% y/y to EUR5.9bn, beating full-year guidance of 5% to 6%.
Bears Say
Competitive AdvantageFirst mover advantage may not last long.
Diagnostics Segment PerformanceDiagnostics revenue growth was modest and the adjusted EBIT was materially below expectations.
Tariffs And Trade BarriersThe adjusted EPS forecast range was widened from EUR2.35 to EUR2.50 originally to EUR2.20 to EUR2.50 to factor in anticipated impacts from tariffs and trade barriers which may affect operations in key markets.
Siemens Healthineers AG News
SHL FAQ
What was Siemens Healthineers’s price range in the past 12 months?
Siemens Healthineers lowest stock price was €40.97 and its highest was €58.48 in the past 12 months.
What is Siemens Healthineers’s market cap?
Siemens Healthineers’s market cap is €49.92B.
When is Siemens Healthineers’s upcoming earnings report date?
Siemens Healthineers’s upcoming earnings report date is Feb 05, 2026 which is in 43 days.
How were Siemens Healthineers’s earnings last quarter?
Siemens Healthineers released its earnings results on Nov 05, 2025. The company reported €0.68 earnings per share for the quarter, missing the consensus estimate of €0.687 by -€0.007.
Is Siemens Healthineers overvalued?
According to Wall Street analysts Siemens Healthineers’s price is currently Undervalued.
Does Siemens Healthineers pay dividends?
Siemens Healthineers pays a Annually dividend of €1 which represents an annual dividend yield of 2.13%. See more information on Siemens Healthineers dividends here
What is Siemens Healthineers’s EPS estimate?
Siemens Healthineers’s EPS estimate is 0.46.
How many shares outstanding does Siemens Healthineers have?
Siemens Healthineers has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers’s price movement after its last earnings report?
Siemens Healthineers reported an EPS of €0.68 in its last earnings report, missing expectations of €0.687. Following the earnings report the stock price went down -8.629%.
Which hedge fund is a major shareholder of Siemens Healthineers?
Currently, no hedge funds are holding shares in DE:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€54.44 (11.73% Upside)
€54.44 (11.73% Upside)
Insider Transactions
Bought Shares
Worth $121.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.07%
12-Months-Change
Fundamentals
Return on Equity
11.45%
Trailing 12-Months
Asset Growth
1.43%
Trailing 12-Months
Company Description
Siemens Healthineers
Siemens Healthineers AG (SHL) is a global leader in medical technology and healthcare services, operating as a subsidiary of Siemens AG. The company specializes in diagnostic imaging, laboratory diagnostics, and digital health solutions, providing innovative products and services that enhance patient care and streamline healthcare operations. With a strong portfolio that includes magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and molecular diagnostics, Siemens Healthineers is committed to advancing healthcare through cutting-edge technology and integrated solutions.
SHL Company Deck
SHL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Siemens Healthineers reported a strong fiscal year 2025 with impressive growth and segment performance. However, challenges in China and macroeconomic headwinds, particularly tariffs and foreign exchange, present significant hurdles for fiscal year 2026. Despite these challenges, the company has laid a solid foundation for future growth and profitability.View all DE:SHL earnings summariesSHL Stock 12 Month Forecast
Average Price Target
€54.44
▲(11.73% Upside)
Technical Analysis
Carl Zeiss Meditec
―
Fresenius Medical Care AG & Co. KGaA
―
Fresenius SE & Co. KGaA
―
Merck KGaA
―
Sartorius
―
Options Prices
Currently, No data available
---